Eight Concomitant Publications in Annals of Oncology
The ESMO Congress 2023 in Madrid provided the occasion to disseminate the latest cancer research and provide high-quality education for oncologists all over the world.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Meeting resources now available on OncologyPRO: Access +3.000 slides, webcasts, abstracts & ePosters
The TROP2-directed ADC improved PFS with reduced toxicity compared with chemotherapy in the TROPION-Lung01 trial, but results are not practice-changing
However, lack of OS benefit limits the clinical impact of the findings from the PSMAfore trial
Promising results reported for datopotamab deruxtecan and trastuzumab deruxtecan in HER2-non-amplified breast cancer
Clinically meaningful improvements over standard care were observed in both first and second line, as reported in the MARIPOSA and MARIPOSA-2 phase III trials
Positive signals from early-phase studies suggest that newer molecular technologies may help to disclose the promises of T-cell therapies in different settings
The ESMO Congress 2023 in Madrid provided the occasion to disseminate the latest cancer research and provide high-quality education for oncologists all over the world.
Create your own personalised agenda and browse the scientific programme by day, topic, cancer type and track with the ESMO events app.
IFEMA MADRID
Avda. Del Partenón, 5
28042 Madrid
Spain
ESMO 2023 worked towards the dissemination of the latest data, provided high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world.
Whilst invited Faculty presented live from Madrid, the innovative, LIVE Plus, Congress format offered participants the option to attend in person, in Madrid, or online, through a virtual platform, from 20 to 24 October 2023.
Save the date for ESMO 2024, taking place in Barcelona, Spain, 13-17 September 2024.
-An outstanding scientific & educational event for the oncology community
Andrés Cervantes, Spain
ESMO President
DISCLAIMER
ESMO is a scientific and professional, non-political and non-religious organisation. As such, and in light of the tragic events unfolding in so many parts of the world, ESMO will not accept responsibility for any comments or remarks made during the ESMO Congress 2023 by session chairs, invited speakers, presenters, members or any other contributor, formally or informally, which might cause offence or be perceived as being biased.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.